Abstract:A bstract Among virtual screening methods that have been developed to facilitate the drug discovery process, chemogenomics presents the particularity to tackle the question of predicting ligands for proteins, at at scales both in the protein and chemical spaces. Therefore, in addition to to predict drug candidates for a given therapeutic protein target, like more classical ligand-based or receptor-based methods do, chemogenomics can also predict off-targets at the proteome level, and therefore, identify potential side-effects or drug repositioning opportunities. In this study, we study and compare machine-learning and deep learning approaches for chemogenomics, that are applicable to screen large sets of compounds against large sets of druggable proteins. State-of-the-art drug chemogenomics methods rely on expert-based chemical and protein descriptors or similarity measures. The recent development of deep learning approaches enabled to design algorithms that learn numerical abstract representations of molecular graphs and protein sequences in an end-to-end fashion, i.e., so that the learnt features optimise the objective function of the drug-target interaction prediction task. In this paper, we address drug-target interaction prediction at the druggable proteome-level, with what we define as the chemogenomic neuron network. This network consists of a feed-forward neuron network taking as input the combination of molecular and protein representations learnt by molecular graph and protein sequence encoders. We first propose a standard formulation of this chemogenomic neuron network. Then, we compare the performances of the standard chemogenomic network to reference deep learning or shallow (machine-learning without deep learning) methods. In particular, we show that such a representation learning approach is competitive with state-of-the-art chemogenomics with shallow methods, but not ultimately superior. We evaluate the most promising neuron network architectures and data augmentation techniques, such as multi-view and transfer learning, to improve the prediction performance of the chemogenomic network. Our results shed new insights on the design of chemogenomics approaches based on representation learning algorithms. Most importantly, we conclude from our observations that a promising research direction is to integrate heterogeneous sources of data such as various bioactivity datasets, or independently, multiple molecule and protein attribute views, instead of focusing on sophisticated, yet intuitively relevant, encoder’s neuron network architecture.

Profiling prediction of nuclear receptor modulators with multi-task deep learning methods: toward the virtual screening

A Case-Based Meta-Learning Algorithm Boosts the Performance of Structure-Based Virtual Screening.

An Ensemble Learning-Based Method for Inferring Drug-Target Interactions Combining Protein Sequences and Drug Fingerprints

Combining graph neural networks and transformers for few-shot nuclear receptor binding activity prediction

Comparative study between deep learning and QSAR classifications for TNBC inhibitors and novel GPCR agonist discovery

RealVS: Toward Enhancing the Precision of Top Hits in Ligand-Based Virtual Screening of Drug Leads from Large Compound Databases

Finding the Molecular Scaffold of Nuclear Receptor Inhibitors Through High-Throughput Screening Based on Proteochemometric Modelling

A Systematic Prediction Of Multiple Drug-Target Interactions From Chemical, Genomic, And Pharmacological Data

Docking-based Virtual Screening with Multi-Task Learning

Kinome-Wide Virtual Screening by Multi-Task Deep Learning

DeepREAL: A Deep Learning Powered Multi-scale Modeling Framework Towards Predicting Out-of-distribution Receptor Activity of Ligand Binding

Improved genome-scale multi-target virtual screening via a novel collaborative filtering approach to cold-start problem

Application of Machine Learning Methods in Predicting Nuclear Receptors and their Families

Large-scale comparison of machine learning methods for profiling prediction of kinase inhibitors

Consensus holistic virtual screening for drug discovery: a novel machine learning model approach

Using Deep Learning for Compound Selectivity Prediction

Prediction of human cytochrome P450 inhibition using a multi-task deep autoencoder neural network.

Drug - Target Interaction Prediction with a Deep-Learning-based Model.

Accurate Prediction of Nuclear Receptors with Conjoint Triad Feature

Machine Learning-Enabled Pipeline for Large-Scale Virtual Drug Screening

Evaluation of network architecture and data augmentation methods for deep learning in chemogenomics